- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04583891
Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design
September 28, 2023 updated by: Philip Chow, Ph.D., University of Virginia
Evaluating a Mobile Application to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design
The overarching goals of this project are to provide the first rigorous test of a scalable and publicly accessible mobile health intervention (IntelliCare) to address emotional distress in women with breast cancer, and to test the impact of human coaching as a way to increase engagement with digital health interventions to improve outcomes.
To achieve these goals, an innovative experimental study design, known as a Sequential, Multiple Assignment, Randomized Trial (SMART), will be used to test the effects of the IntelliCare apps on symptoms of depression and anxiety, as well as the added value of human support to improve participant engagement.
313 breast cancer survivors diagnosed within the past 5 years and who screen positive for elevated symptoms of depression and/or anxiety will be recruited.
Participants will initially be randomized to receive the IntelliCare apps or app-delivered patient education (control) for 8 weeks, and the impact of the IntelliCare apps on reducing symptoms of depression and anxiety in breast cancer survivors relative to control will be tested (Aim 1).
We will monitor the app usage data of participants who receive the IntelliCare apps.
Those who are high-engagers will continue to use the apps with no change.
Those who are low-to-moderate engagers will be rerandomized after 1 week to either receive added coaching vs. not (i.e., no change) in addition to the apps.
The hypothesis is that added coaching to address barriers to app usage will lead to greater engagement with the apps (Aim 2), for low-to-moderate engagers.
Finally, semi-structured exit interviews will be conducted with participants that receive the IntelliCare apps and coaching.
Interviews will capture survivors' perceptions about the extent to which, and how, tailoring the apps and coaching specifically for breast cancer survivors may improve intervention outcomes and engagement (Aim 3).
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
314
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Philip Chow, PhD
- Phone Number: 434-924-5401
- Email: pic2u@virginia.edu
Study Contact Backup
- Name: Laurie Bennett
- Phone Number: 4342434239
- Email: LB2QB@hscmail.mcc.virginia.edu
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22904
- University of Virginia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- age ≥ 18 years (age 19 if in Nebraska, given age of consent);
- 0-5 years post-diagnosis of Stage I, II, or III female breast cancer;
- elevated symptoms of depression as measured by the Patient Health Questionnaire-8 (PHQ-8) score ≥ 10 and/or symptoms of anxiety as measured by the Generalized Anxiety Disorder-7 (GAD-7) score ≥ 8.
Exclusion Criteria:
- Taking antidepressant medication and have had an appointment to adjust the dosage over the past 2 weeks;
- mental health condition deemed to interfere with study procedures or put the participant at undue risk based on self-reported history of psychosis or bipolar disorder, or active suicidal ideation that necessitates more intense care;
- do not have an app-compatible phone (i.e., iOS 10.3 or later or Android 4.0.3 or later);
- cannot read and speak English (current intervention only available in English).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: IntelliCare
IntelliCare is a self-guided, fully automated suite of apps designed for brief, frequent check-ins to promote skill acquisition.
IntelliCare has been shown in both general deployment and human-supported trials to be efficacious in reducing symptoms of depression and anxiety.
|
IntelliCare is a self-guided, fully automated suite of 6 apps designed for brief, frequent check-ins to promote skill acquisition.
IntelliCare has been shown in both general deployment and human-supported trials to be efficacious in reducing symptoms of depression and anxiety.
The randomization of added coaching vs. no added coaching after 1 week will only be carried out in the IntelliCare group.
Coaching is a human supported approach to optimizing the use and benefit of the IntelliCare apps.
|
Active Comparator: Patient Education
The patient education app will contain psychoeducational information about distress prevalence and distress management.
It will serve as an active control condition to compare with the IntelliCare apps.
|
The Patient Education app will contain content relevant for general distress management.
This includes information about thoughts/worries, prevalence of mood symptoms, CBT strategies for coping with negative affect, and other information typical of education-based mental health apps.
The structure of this app will closely mirror patient education websites and apps which mimic the form and structure of apps that target cancer survivors and that primarily provide educational information about cancer and related symptoms.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Health Questionnaire-8
Time Frame: Baseline
|
8 item scale that measures depression symptoms on a continuous scale.
Scores range from 0-24, with a higher score indicating greater severity of symptoms of depression.
|
Baseline
|
Patient Health Questionnaire-8
Time Frame: 8 weeks
|
8 item scale that measures depression symptoms on a continuous scale.
Scores range from 0-24, with a higher score indicating greater severity of symptoms of depression.
|
8 weeks
|
Patient Health Questionnaire-8
Time Frame: 6 months
|
9 item scale that measures depression symptoms on a continuous scale.
Scores range from 0-24, with a higher score indicating greater severity of symptoms of depression.
|
6 months
|
Patient Health Questionnaire-8
Time Frame: 12 months
|
8 item scale that measures depression symptoms on a continuous scale.
Scores range from 0-24, with a higher score indicating greater severity of symptoms of depression.
|
12 months
|
Generalized Anxiety Disorder-7
Time Frame: Baseline
|
7 item scale that measures anxiety symptoms on a continuous scale.
Scores range from 0-21, with a higher score indicating greater severity of symptoms of anxiety.
|
Baseline
|
Generalized Anxiety Disorder-7
Time Frame: 8 weeks
|
7 item scale that measures anxiety symptoms on a continuous scale.
Scores range from 0-21, with a higher score indicating greater severity of symptoms of anxiety.
|
8 weeks
|
Generalized Anxiety Disorder-7
Time Frame: 6 months
|
7 item scale that measures anxiety symptoms on a continuous scale.
Scores range from 0-21, with a higher score indicating greater severity of symptoms of anxiety.
|
6 months
|
Generalized Anxiety Disorder-7
Time Frame: 12 months
|
7 item scale that measures anxiety symptoms on a continuous scale.
Scores range from 0-21, with a higher score indicating greater severity of symptoms of anxiety.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
App Engagement from App Sessions
Time Frame: Frequency of unique app sessions from Baseline through 8 weeks
|
Number of app sessions
|
Frequency of unique app sessions from Baseline through 8 weeks
|
App Engagement from App Session Duration
Time Frame: Duration in seconds of app sessions from Baseline through 8 weeks
|
App session duration
|
Duration in seconds of app sessions from Baseline through 8 weeks
|
App Engagement from App Downloads
Time Frame: Number of apps downloaded from Baseline through 8 weeks
|
App downloads
|
Number of apps downloaded from Baseline through 8 weeks
|
36-Item Short Form Survey
Time Frame: Baseline
|
The SF-36 is a 36 item scale that is composed of 2 summary scores that measure health status related to both physical and mental health.
Scores for each domain range from 0-100, with higher scores indicating better health status.
|
Baseline
|
36-Item Short Form Survey
Time Frame: 8 weeks
|
The SF-36 is a 36 item scale that is composed of 2 summary scores that measure health status related to both physical and mental health.
Scores for each domain range from 0-100, with higher scores indicating better health status.
|
8 weeks
|
36-Item Short Form Survey
Time Frame: 6 months
|
The SF-36 is a 36 item scale that is composed of 2 summary scores that measure health status related to both physical and mental health.
Scores for each domain range from 0-100, with higher scores indicating better health status.
|
6 months
|
36-Item Short Form Survey
Time Frame: 12 months
|
The SF-36 is a 36 item scale that is composed of 2 summary scores that measure health status related to both physical and mental health.
Scores for each domain range from 0-100, with higher scores indicating better health status.
|
12 months
|
Multidimensional Fatigue Symptom Inventory-Short Form
Time Frame: Baseline
|
Fatigue will be measured using the MFSI-SF, which is a 30 item self-report measure comprised of five subscales (general, emotional, physical, mental, vigor) and a total fatigue score.
Each subscale score ranges from 0 to 24.
The Total MSFI-SF score is calculated by adding the general, physical, emotional and mental subscale scores and subtracting vigor subscale score.
Total MFSI-SF score ranges from -24 to 96 with a higher score indicating higher levels of cancer-related fatigue experienced by the patient.
|
Baseline
|
Multidimensional Fatigue Symptom Inventory-Short Form
Time Frame: 8 weeks
|
Fatigue will be measured using the MFSI-SF, which is a 30 item self-report measure comprised of five subscales (general, emotional, physical, mental, vigor) and a total fatigue score.
Each subscale score ranges from 0 to 24.
The Total MSFI-SF score is calculated by adding the general, physical, emotional and mental subscale scores and subtracting vigor subscale score.
Total MFSI-SF score ranges from -24 to 96 with a higher score indicating higher levels of cancer-related fatigue experienced by the patient.
|
8 weeks
|
Multidimensional Fatigue Symptom Inventory-Short Form
Time Frame: 6 months
|
Fatigue will be measured using the MFSI-SF, which is a 30 item self-report measure comprised of five subscales (general, emotional, physical, mental, vigor) and a total fatigue score.
Each subscale score ranges from 0 to 24.
The Total MSFI-SF score is calculated by adding the general, physical, emotional and mental subscale scores and subtracting vigor subscale score.
Total MFSI-SF score ranges from -24 to 96 with a higher score indicating higher levels of cancer-related fatigue experienced by the patient.
|
6 months
|
Multidimensional Fatigue Symptom Inventory-Short Form
Time Frame: 12 months
|
Fatigue will be measured using the MFSI-SF, which is a 30 item self-report measure comprised of five subscales (general, emotional, physical, mental, vigor) and a total fatigue score.
Each subscale score ranges from 0 to 24.
The Total MSFI-SF score is calculated by adding the general, physical, emotional and mental subscale scores and subtracting vigor subscale score.
Total MFSI-SF score ranges from -24 to 96 with a higher score indicating higher levels of cancer-related fatigue experienced by the patient.
|
12 months
|
Pittsburgh Sleep Quality Index
Time Frame: Baseline
|
The Pittsburgh Sleep Quality Index contains 19 self-rated questions that assesses sleep quality and disturbances.
Global scores range from 0-21, with a score of 5 or more indicating poor sleep quality.
The higher the score, the worse the sleep quality.
|
Baseline
|
Pittsburgh Sleep Quality Index
Time Frame: 8 weeks
|
The Pittsburgh Sleep Quality Index contains 19 self-rated questions that assesses sleep quality and disturbances.
Global scores range from 0-21, with a score of 5 or more indicating poor sleep quality.
The higher the score, the worse the sleep quality.
|
8 weeks
|
Pittsburgh Sleep Quality Index
Time Frame: 6 months
|
The Pittsburgh Sleep Quality Index contains 19 self-rated questions that assesses sleep quality and disturbances.
Global scores range from 0-21, with a score of 5 or more indicating poor sleep quality.
The higher the score, the worse the sleep quality.
|
6 months
|
Pittsburgh Sleep Quality Index
Time Frame: 12 months
|
The Pittsburgh Sleep Quality Index contains 19 self-rated questions that assesses sleep quality and disturbances.
Global scores range from 0-21, with a score of 5 or more indicating poor sleep quality.
The higher the score, the worse the sleep quality.
|
12 months
|
Alcohol Use Disorders Identification Test
Time Frame: Baseline
|
The Alcohol Use Disorders Identification Test contains 10 questions (each question is scored 0-4).
The range of possible scores is from 0 to 40 where 0 indicates an abstainer who has never had any problems from alcohol.
A score of 1 to 7 suggests low-risk consumption according to World Health Organization (WHO) guidelines.
Scores from 8 to 14 suggest hazardous or harmful alcohol consumption and a score of 15 or more indicates the likelihood of alcohol dependence (moderate-severe alcohol use disorder).
|
Baseline
|
Alcohol Use Disorders Identification Test
Time Frame: 8 weeks
|
The Alcohol Use Disorders Identification Test contains 10 questions (each question is scored 0-4).
The range of possible scores is from 0 to 40 where 0 indicates an abstainer who has never had any problems from alcohol.
A score of 1 to 7 suggests low-risk consumption according to World Health Organization (WHO) guidelines.
Scores from 8 to 14 suggest hazardous or harmful alcohol consumption and a score of 15 or more indicates the likelihood of alcohol dependence (moderate-severe alcohol use disorder).
|
8 weeks
|
Alcohol Use Disorders Identification Test
Time Frame: 6 months
|
The Alcohol Use Disorders Identification Test contains 10 questions (each question is scored 0-4).
The range of possible scores is from 0 to 40 where 0 indicates an abstainer who has never had any problems from alcohol.
A score of 1 to 7 suggests low-risk consumption according to World Health Organization (WHO) guidelines.
Scores from 8 to 14 suggest hazardous or harmful alcohol consumption and a score of 15 or more indicates the likelihood of alcohol dependence (moderate-severe alcohol use disorder).
|
6 months
|
Alcohol Use Disorders Identification Test
Time Frame: 12 months
|
The Alcohol Use Disorders Identification Test contains 10 questions (each question is scored 0-4).
The range of possible scores is from 0 to 40 where 0 indicates an abstainer who has never had any problems from alcohol.
A score of 1 to 7 suggests low-risk consumption according to World Health Organization (WHO) guidelines.
Scores from 8 to 14 suggest hazardous or harmful alcohol consumption and a score of 15 or more indicates the likelihood of alcohol dependence (moderate-severe alcohol use disorder).
|
12 months
|
PROMIS Global Health v1.2
Time Frame: Baseline
|
The PROMIS Global Health scale v1.2 contains 7 items that measure physical and mental health.
Each question is scored on a 1-5 scale with a total score range of 7-35.
Higher scores indicate better overall health.
|
Baseline
|
PROMIS Global Health v1.2
Time Frame: 8 weeks
|
The PROMIS Global Health scale v1.2 contains 7 items that measure physical and mental health.
Each question is scored on a 1-5 scale with a total score range of 7-35.
Higher scores indicate better overall health.
|
8 weeks
|
PROMIS Global Health v1.2
Time Frame: 6 months
|
The PROMIS Global Health scale v1.2 contains 7 items that measure physical and mental health.
Each question is scored on a 1-5 scale with a total score range of 7-35.
Higher scores indicate better overall health.
|
6 months
|
PROMIS Global Health v1.2
Time Frame: 12 months
|
The PROMIS Global Health scale v1.2 contains 7 items that measure physical and mental health.
Each question is scored on a 1-5 scale with a total score range of 7-35.
Higher scores indicate better overall health.
|
12 months
|
PROMIS Satisfaction with Sex Life
Time Frame: Baseline
|
The PROMIS Satisfaction with Sex Life scale v.20 contains 5 items that measure satisfaction with one's sex life.
Each question is scored on a 1-5 scale with a total score range of 5-25.
Higher scores indicate higher satisfaction with one's sex life.
|
Baseline
|
PROMIS Satisfaction with Sex Life
Time Frame: 8 weeks
|
The PROMIS Satisfaction with Sex Life scale v.20 contains 5 items that measure satisfaction with one's sex life.
Each question is scored on a 1-5 scale with a total score range of 5-25.
Higher scores indicate higher satisfaction with one's sex life.
|
8 weeks
|
PROMIS Satisfaction with Sex Life
Time Frame: 6 months
|
The PROMIS Satisfaction with Sex Life scale v.20 contains 5 items that measure satisfaction with one's sex life.
Each question is scored on a 1-5 scale with a total score range of 5-25.
Higher scores indicate higher satisfaction with one's sex life.
|
6 months
|
PROMIS Satisfaction with Sex Life
Time Frame: 12 months
|
The PROMIS Satisfaction with Sex Life scale v.20 contains 5 items that measure satisfaction with one's sex life.
Each question is scored on a 1-5 scale with a total score range of 5-25.
Higher scores indicate higher satisfaction with one's sex life.
|
12 months
|
UAMS Health Literacy Measure
Time Frame: Baseline
|
The UAMS Health Literacy measure consists of 3 items that assess health literacy.
Each question is scored on a 1-5 scale, with a possible total score range of 3-15.
Higher scores indicate worse health literacy.
|
Baseline
|
UAMS Health Literacy Measure
Time Frame: 8 weeks
|
The UAMS Health Literacy measure consists of 3 items that assess health literacy.
Each question is scored on a 1-5 scale, with a possible total score range of 3-15.
Higher scores indicate worse health literacy.
|
8 weeks
|
UAMS Health Literacy Measure
Time Frame: 6 months
|
The UAMS Health Literacy measure consists of 3 items that assess health literacy.
Each question is scored on a 1-5 scale, with a possible total score range of 3-15.
Higher scores indicate worse health literacy.
|
6 months
|
UAMS Health Literacy Measure
Time Frame: 12 months
|
The UAMS Health Literacy measure consists of 3 items that assess health literacy.
Each question is scored on a 1-5 scale, with a possible total score range of 3-15.
Higher scores indicate worse health literacy.
|
12 months
|
Penn State Worry Questionnaire
Time Frame: Baseline
|
The Penn State Worry Questionnaire consists of 16 items that assess the trait of worry.
Each question is scored on a 1-5 scale with a possible total score range of 16-80.
Higher scores indicate higher levels of trait worry.
|
Baseline
|
Penn State Worry Questionnaire
Time Frame: 8 weeks
|
The Penn State Worry Questionnaire consists of 16 items that assess the trait of worry.
Each question is scored on a 1-5 scale with a possible total score range of 16-80.
Higher scores indicate higher levels of trait worry.
|
8 weeks
|
Penn State Worry Questionnaire
Time Frame: 6 months
|
The Penn State Worry Questionnaire consists of 16 items that assess the trait of worry.
Each question is scored on a 1-5 scale with a possible total score range of 16-80.
Higher scores indicate higher levels of trait worry.
|
6 months
|
Penn State Worry Questionnaire
Time Frame: 12 months
|
The Penn State Worry Questionnaire consists of 16 items that assess the trait of worry.
Each question is scored on a 1-5 scale with a possible total score range of 16-80.
Higher scores indicate higher levels of trait worry.
|
12 months
|
Ten Item Personality Inventory
Time Frame: Baseline
|
The Ten Item Personality Inventory consists of 10 items that assess the Big 5 personality domains (i.e., conscientiousness, openness, agreeableness, extraversion, neuroticism).
Each personality domain is assessed by 2 items.
Each item is scored on a 1-7 scale.
Higher scores on each personality trait domain indicates higher levels of that personality trait.
|
Baseline
|
Ten Item Personality Inventory
Time Frame: 8 weeks
|
The Ten Item Personality Inventory consists of 10 items that assess the Big 5 personality domains (i.e., conscientiousness, openness, agreeableness, extraversion, neuroticism).
Each personality domain is assessed by 2 items.
Each item is scored on a 1-7 scale.
Higher scores on each personality trait domain indicates higher levels of that personality trait.
|
8 weeks
|
Ten Item Personality Inventory
Time Frame: 6 months
|
The Ten Item Personality Inventory consists of 10 items that assess the Big 5 personality domains (i.e., conscientiousness, openness, agreeableness, extraversion, neuroticism).
Each personality domain is assessed by 2 items.
Each item is scored on a 1-7 scale.
Higher scores on each personality trait domain indicates higher levels of that personality trait.
|
6 months
|
Ten Item Personality Inventory
Time Frame: 12 months
|
The Ten Item Personality Inventory consists of 10 items that assess the Big 5 personality domains (i.e., conscientiousness, openness, agreeableness, extraversion, neuroticism).
Each personality domain is assessed by 2 items.
Each item is scored on a 1-7 scale.
Higher scores on each personality trait domain indicates higher levels of that personality trait.
|
12 months
|
TWente Engagement with Ehealth Technologies Scale (TWEETS)
Time Frame: Baseline
|
The TWEETS scale consists of 9 items on a 5-point Likert scale (0-4).
Of the 9 items, 3 are aimed at assessing behavioral engagement, 3 on cognitive engagement, and 3 of affective engagement.
Higher scores indicate higher levels on each of the engagement domains.
|
Baseline
|
TWente Engagement with Ehealth Technologies Scale (TWEETS)
Time Frame: 8 weeks
|
The TWEETS scale consists of 9 items on a 5-point Likert scale (0-4).
Of the 9 items, 3 are aimed at assessing behavioral engagement, 3 on cognitive engagement, and 3 of affective engagement.
Higher scores indicate higher levels on each of the engagement domains.
|
8 weeks
|
TWente Engagement with Ehealth Technologies Scale (TWEETS)
Time Frame: 6 months
|
The TWEETS scale consists of 9 items on a 5-point Likert scale (0-4).
Of the 9 items, 3 are aimed at assessing behavioral engagement, 3 on cognitive engagement, and 3 of affective engagement.
Higher scores indicate higher levels on each of the engagement domains.
|
6 months
|
TWente Engagement with Ehealth Technologies Scale (TWEETS)
Time Frame: 12 months
|
The TWEETS scale consists of 9 items on a 5-point Likert scale (0-4).
Of the 9 items, 3 are aimed at assessing behavioral engagement, 3 on cognitive engagement, and 3 of affective engagement.
Higher scores indicate higher levels on each of the engagement domains.
|
12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Digital Intervention Evaluation Questionnaire
Time Frame: 8 weeks
|
A single questionnaire with subscales of perceived utility and perceived impact; 18 items each scored on a 0 (not at all) to 5 (very) scale
|
8 weeks
|
Digital Intervention Adherence Questionnaire
Time Frame: 8 weeks
|
A single questionnaire that assesses barriers to program use; 32 items each scored on a 0 (not at all) to 2 (very) scale
|
8 weeks
|
Limited List of Questions for Exit Interview
Time Frame: 8 weeks
|
Only those that receive the IntelliCare apps will be administered a qualitative interview that contains items assessing how the app intervention met their needs as a breast cancer survivor and possible changes to improve fit.
Study staff will administer this interview on the phone.
10 questions will assess overall impressions of the IntelliCare app program.
Additional questions will focus on specific apps within the IntelliCare program and how they can be tailored in future studies.
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 27, 2021
Primary Completion (Estimated)
January 31, 2024
Study Completion (Estimated)
November 30, 2024
Study Registration Dates
First Submitted
August 25, 2020
First Submitted That Met QC Criteria
October 6, 2020
First Posted (Actual)
October 12, 2020
Study Record Updates
Last Update Posted (Actual)
September 29, 2023
Last Update Submitted That Met QC Criteria
September 28, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200218
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Engagement, Patient
-
Cedars-Sinai Medical CenterTerminated
-
University of AarhusUnknownPatient Engagement | Patient Empowerment | Patient Compliance
-
The University of Texas at ArlingtonAgency for Healthcare Research and Quality (AHRQ)RecruitingPatient Engagement | Patient Empowerment | Patient ActivationUnited States
-
Inonu UniversityCompleted
-
University of WashingtonNational Institute of Mental Health (NIMH); Mental Health America; TalkspaceRecruiting
-
The Cleveland ClinicRecruitingPatient EngagementUnited States
-
University of North Carolina, Chapel HillCompleted
-
Medical College of WisconsinCompletedCommunication | Patient EngagementUnited States
-
Palo Alto Medical FoundationUniversity of Rochester; Dartmouth College; Gordon and Betty Moore Foundation; ... and other collaboratorsCompletedPatient Engagement | Physician's Role | Physician-Patient Relationship
-
NYU Langone HealthCompleted
Clinical Trials on IntelliCare
-
Adaptive Health, IncRecruitingDepression | AnxietyUnited States
-
Actualize TherapyUniversity of ArkansasCompletedDepression | Anxiety | Primary Health CareUnited States
-
Camlin LtdUniversità Politecnica delle MarcheCompletedParkinson Disease | Post-COVID19Italy
-
Northwestern UniversityCompletedAnxiety Disorders | Major Depressive DisorderUnited States
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH)RecruitingDepression | Anxiety DisordersUnited States
-
University of VirginiaUnknownDepression | Anxiety | Mental Health Wellness 1United States
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedStroke | Multiple Sclerosis | Parkinson DiseaseItaly
-
Northwestern UniversityBrown UniversityActive, not recruiting
-
Northwestern UniversityNational Institute of Mental Health (NIMH)Completed
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH)CompletedToward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part IDepression, AnxietyUnited States